The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
Market view
fenofibrate · Powder
14 marketed package NDCs · 11 active manufacturers
Most dispensed: 200 mg · Capsule · #100 capsules/bottle · 134 mg · Capsule · #100 capsules/bottle · 67 mg · Capsule · #100 capsules/bottle · 160 mg · Tablet, Film Coated · #90 tablet, film coateds/bottle
What changed in the last 90 days
Every detected change for fenofibrate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- FenofibrateAug 19, 2026Price upNADAC $0.11977 → $0.12141 per unit (+1.37%)
- FenofibrateAug 19, 2026Price upNADAC $16.93973 → $16.95398 per unit (+0.08%)
- FenofibrateAug 19, 2026Price downNADAC $5.72475 → $5.67776 per unit (-0.82%)
- FenofibrateAug 19, 2026Price upNADAC $0.11192 → $0.1129 per unit (+0.88%)
- FenofibrateAug 19, 2026Price upNADAC $0.11192 → $0.1129 per unit (+0.88%)
- FenofibrateAug 19, 2026Price downNADAC $0.08553 → $0.07792 per unit (-8.9%)
- FenofibrateAug 19, 2026Price upNADAC $0.11192 → $0.1129 per unit (+0.88%)
- FenofibrateAug 19, 2026Price upNADAC $0.11192 → $0.1129 per unit (+0.88%)
- FenofibrateAug 19, 2026Price downNADAC $0.08553 → $0.07792 per unit (-8.9%)
- FenofibrateAug 19, 2026Price downNADAC $0.08553 → $0.07792 per unit (-8.9%)
Same drug class
Other molecules FDA puts in Peroxisome Proliferator Receptor alpha Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- alogliptin and pioglitazone· 1 maker
- pioglitazole and metformin hydrochloride· 1 maker
- pioglitazone hcl and metformin hcl· 1 maker
- alogliptin benzoate and pioglitazone hydrochloride· 2 makers
- pioglitazone and glimepiride· 3 makers
- pioglitazone and metformin hydrochloride· 3 makers
- pioglitazone hydrochloride and metformin hydrochloride· 3 makers
- fenofibric acid· 11 makers
- pioglitazone· 19 makers
- pioglitazone hydrochloride· 19 makers
- gemfibrozil· 31 makers
Common questions
- Is Fenofibrate in shortage right now?
- No. FDA does not currently list Fenofibrate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Fenofibrate?
- 66 companies have marketed Fenofibrate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Fenofibrate cost?
- The typical pharmacy pays about $0.1129 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.